| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |